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Abstract
Background: Several systematic reviews and meta-analyses populate the literature on the effectiveness of
laparoscopic surgery for colorectal cancer. The utility of this body of work is unclear. The objective of this study
was to synthesize all such systematic reviews in terms of clinical effectiveness, to appraise their quality, and to
determine whether areas of duplication exist across reviews.
Methods: Systematic reviews comparing laparoscopic and open surgery for colorectal cancer were identified using
a comprehensive search protocol (1991 to 2008). The primary outcome was overall survival. The methodological
quality of reviews was appraised using the Assessment of Multiple Systematic Reviews (AMSTAR) instrument.
Abstraction and quality appraisal was carried out by two independent reviewers. Reviews were synthesized, and
outcomes were compared qualitatively. A citation analysis was carried out using simple matrices to assess the
comprehensiveness of each review.
Results: In total, 27 reviews were included; 13 reviews included only randomized controlled trials. Rectal cancer
was addressed exclusively by four reviews. There was significant overlap between review purposes, populations
and, outcomes. The mean AMSTAR score (out of 11) was 5.8 (95% CI: 4.6 to 7.0). Overall survival was evaluated by
ten reviews, none of which found a significant difference. Three reviews provided a selective meta-analysis of time-
to-event data. Previously published systematic reviews were poorly and highly selectively referenced (mean citation
ratio 0.16, 95% CI: 0.093 to 0.22). Previously published trials were not comprehensively identified and cited (mean
citation ratio 0.56, 95% CI: 0.46 to 0.65).
Conclusions: Numerous overlapping systematic reviews of laparoscopic and open surgery for colorectal cancer
exist in the literature. Despite variable methods and quality, survival outcomes are congruent across reviews. A
duplication of research efforts appears to exist in the literature. Further systematic reviews or meta-analyses are
unlikely to be justified without specifying a significantly different research objective. This works lends support to
the registration and updating of systematic reviews.
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Background
Any field of active investigation in healthcare requires
t h a tt h eo v e r w h e l m i n gv o l u m eo fc u m u l a t i v ei n f o r m a -
tion generated by individual researchers be condensed
and summarized into a usable product. This synthesis
must be simple, yet comprehensive, so as to inform
decisions and policies carried out by physicians and sur-
geons, hospital administrators, healthcare payers, fund-
ing agencies, and other end users of research and
outcomes data. Systematic reviews are widely considered
to be the most comprehensive and unbiased method to
do so [1]. On the basis of their completeness, such
reviews should remain unique in the literature and be
updated frequently, rather than duplicated or compart-
mentalized. In this context, some authors have recently
advocated for the open registration of systematic reviews
[2-4].
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1991 by Fowler and White [5] and by Jacobs and collea-
gues [6]. This technology has since been applied to
almost every disease process, whether benign or malig-
nant, involving the colon and rectum [7]. The use of
laparoscopy rather than traditional open laparotomy to
treat colorectal cancer has generated tremendous con-
troversy in the surgical literature, particularly as con-
cerns the oncologic adequacy of this technique. Many
investigators have attempted to address this issue, and
have thus generated a large body of literature over the
past 20 years. Published studies have included the entire
spectrum of research data, ranging from small personal
case series to large nationally funded multicenter rando-
mized controlled trials (RCTs). This work presents an
excellent opportunity for a case study of research synth-
esis and knowledge translation processes in surgical
research, an area that has traditionally lacked investiga-
tive rigor [8].
Numerous systematic reviews and meta-analyses per-
taining to laparoscopic surgery for colorectal cancer
have been published. Informal examination of these
reviews would suggest significant overlap and possible
duplication. The utility of this body of work is unclear
at this time. As such, we set out to examine and
appraise all existing systematic reviews of laparoscopic
colorectal surgery for cancer, both in terms of clinical
outcomes and their relative completeness, methodologi-
cal quality, and overlap.
Methods
This overview of systematic reviews was carried out
using the framework for umbrella reviews described by
the Cochrane Collaboration [9]. This approach consisted
of identifying all existing systematic reviews and meta-
analyses pertaining to laparoscopic surgery for colorectal
cancer. This work was part of a larger review effort
addressing both primary publications and review papers,
the results of which will be presented separately. A
review protocol was utilized for the project as a whole.
Criteria for considering reviews for inclusion
All inclusion and exclusion criteria were defined a priori.
All systematic reviews and meta-analyses addressing
laparoscopic and open surgery for colorectal cancer were
included. For this purpose, all reviews were allowable if
they were self-described as systematic, whether in the title,
abstract, or methods of the paper. Alternatively, a citation
was also allowable if the authors presented a meta-analysis
of primary papers or utilized meta-analytic techniques to
pool primary data. These criteria were utilized regardless
of the quality or comprehensiveness of the review. The
type of primary data papers included in the citations could
be RCTs, observational studies, or both.
All included citations reviewed primary papers addres-
sing the curative resection of colon and/or rectal cancer.
Patients with colorectal cancer did not have to be the
sole population under review. Laparoscopic resection for
colorectal cancer was the intervention under study.
Included reviews had to present a comparison to an
open resection control group.
The primary outcome of interest was overall survival.
Secondary endpoints were also considered if they were
included in a review of interest: operative outcomes,
short-term postoperative outcomes, oncologic surrogate
outcomes, long-term oncologic outcomes, other long-
term outcomes, and quality of life. A review could be
included in this overview even if no data pertaining to
survival was presented, as identification of review deficits
was a prespecified objective of our work. Reviews addres-
sing exclusively cost or immune function were excluded.
Search methods for identification of reviews
Systematic reviews and meta-analyses were identified as
part of a broader comprehensive search strategy designed
to identify primary comparative literature pertaining to
laparoscopic and open surgery for colorectal cancer. The
final search algorithm was devised in conjunction with an
experienced information specialist from the Ottawa Hos-
pital Library (Additional file 1). This search strategy was
designed to be highly sensitive, and was modified from
previously published work [10]. Six major databases were
searched for relevant citations from 1991 to 2008 (Ovid
MEDLINE, Ovid EMBASE, Cochrane Library, Science
Citation Index Expanded, BIOSIS Preview, and BIREME
LILACS). An additional 13 databases were also searched
for relevant citations (Database of Abstracts of Reviews
of Effectiveness, Heath Technology Assessment Database,
NHS Economic Evaluation Database, NIHR Health Tech-
nology Assessment Programme, Trip Database, Clinical-
trials.gov, Controlled-trials.com, National Guidelines
Clearinghouse, CMA Infobase: Clinical Practice Guide-
lines, NICE England, SIGN Scotland, NHMRC Australia,
New Zealand Guidelines Group). The reference lists of
all included citations were also screened to identify miss-
ing reviews. No language limitation was applied to the
search strategy. All citation records were retrieved and
downloaded electronically using Reference Manager 10
(ISI ResearchSoft, Berkeley, CA, USA), and were then de-
duplicated.
Selection of reviews
All citations were first screened for inclusion by one
reviewer (GM) on the basis of titles and abstracts (Fig-
ure 1). All retained citations were then retrieved in full
text. Papers that could not be obtained after extensive
interlibrary searching were considered missing. Papers
published in languages other than English, French, or
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(Google Inc., Mountain View, CA, USA). Full-text arti-
cles were evaluated for inclusion by one reviewer (GM).
Included articles were then classified as (1) data papers
or (2) review papers. Review papers were then further
divided as systematic reviews/meta-analyses, narrative
reviews, textbook chapters, and guidelines/position
papers. Only systematic reviews/meta-analyses were
considered in the current work, while all other included
paper types were set aside for a separate research
project. All included systematic reviews were further
evaluated for inclusion by a second reviewer (SD), and
disagreements between the two reviewers was resolved
by discussion and consensus.
Data extraction and management
A total of 6 study characteristics and 19 prespecified
outcomes of interests were extracted by two reviewers
(GM, SD) onto data tables designed ap r i o r i(Table 1).
All discrepancies were resolved by discussion and
Figure 1 PRISMA diagram [95]. Note that the total number of data and review articles does not add up to 669, as 9 papers were included in
both categories.
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comparison of laparoscopic to open surgery. Where
papers compared open to laparoscopic surgery, the
appropriate reciprocal relative measure of effect and
reciprocal measure of significance were calculated and
recorded. The relative measures of effect were main-
tained in the statistical format provided by the authors
of individual citations.
Assessment of methodological quality of included
reviews
The methodological quality of individual reviews
included in this overview was assessed using the Assess-
ment of Multiple Systematic Reviews (AMSTAR) instru-
ment [11]. This tool consists of 11 individual items,
which were developed from pre-existing instruments,
empirical evidence, and expert consensus. It has been
shown to be valid, reliable, and relatively easy to use
[11-13]. Each item within the instrument can receive 1
point, for a possible range of AMSTAR scores of 0 to
11. The AMSTAR instrument was administered inde-
pendently by two reviewers (GM, SD) and discrepant
scores were resolved by discussion and consensus.
Data synthesis
The data extracted from each included systematic
review was incorporated into summary tables and fig-
ures. The resulting data were synthesized in narrative
form and correlated qualitatively with methodological
AMSTAR scores. The congruence of pooled summary
estimates for outcomes of interest across reviews was
evaluated qualitatively.
As a means of evaluating the appropriateness of
included reviews, a bibliographic analysis was carried
out. Citation matrices [14] were generated that cross-
linked individual reviews with (1) previously published
systematic reviews identifi e di nt h i sw o r k ,a n d( 2 )p u b -
lished RCTs of laparoscopic vs open colorectal cancer
surgery also identified in this work. This technique was
used to determine whether the authors of included
reviews made use of other pre-existing systematic
reviews, and whether the identification of relevant RCTs
was comprehensive. A 1-year lag time to publication
was incorporated into the citation matrices and calcula-
tions. To account for the growing number of publica-
tions in time, the ratio of cited to total pre-existing
publications was calculated for each systematic review.
The mean ratios and 95% confidence interval were cal-
culated for citation of both pre-existing systematic
reviews and RCTs. Finally, citation ratios for individual
systematic reviews were compared to AMSTAR scores
and 5-year impact factors (where available) [15] using
Pearson correlation coefficients.
All calculations and statistical analyses were per-
formed using Microsoft Excel 2010 (Microsoft Corpora-
t i o n ,R i c h m o n d ,W A ,U S A )a n dS A SV .9 . 2( S A S
Institute Inc., Cary, NC, USA).
Results
Description of included reviews
A total of 5,800 single citation records were screened for
inclusion (Figure 1). After applying a 2-step screening
process, a total of 27 full-text systematic reviews and/or
meta-analyses [10,16-41] were included in this overview.
Not included in this final tally was one Chinese lan-
guage review, which could not be translated [42]. Simi-
larly, another systematic review was excluded, as it
focused solely on the methodological quality of RCTs
identified in a Cochrane Review by the same author
[43]. Finally, two more reviews were not considered as
they addressed cost outcomes [44] and hand-assisted vs
standard laparoscopic colorectal surgery [45], respec-
tively. Other primary data papers and reviews identified
in Figure 1 have also been included, and will form the
basis for a separate publication. The full list of citations
is available from the authors upon request.
The characteristics of all included reviews are pro-
vided in Table 2. Included reviews were published
Table 1 List of characteristics and outcomes extracted from each review
Review characteristics Review outcomes
Date assessed as up to date Positive radial margin (%) Postoperative mortality (%, 30 day)
Population Positive distal margin (%) Length of hospital stay (days)
Intervention(s) Radial margin distance (cm) Overall morbidity (%)
Study types Distal margin distance (cm) Local recurrence (%)
a
Reported outcomes Operative time (min) Distal metastases (%)
a
Review limitations Nodes harvested (n)
a Port site or wound metastases (%)
a
Anastomotic leak (%) Cancer-related mortality (%)
a
Pneumonia (%) Disease-free survival (%)
a
Urinary tract infection (%) Overall survival (%)
a
Surgical site infection (%)
aOncologic outcomes included in Additional file 2.
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Review (origin) Last
update
Population/intervention
a Study types Notes/limitations
Bernard/ANDEM,
1994 [16],
(France)
July 1993 Any colorectal pathology and other abdominal
pathologies (appendicitis, biliary disease, reflux,
inguinal hernia)
Case series; no
RCT or
observational
study found
In French. Paucity of available comparative
literature. Broad review addressing all
laparoscopic techniques (biliary, hernia, etc.).
Chapman/
ASERNIP-S 2000
[17] (Australia)
July 1999 Colon cancer (right, left/sigmoid) and animal
studies of in vitro/in vivo tumor spread.
Excluded: transverse colectomy, APR, total
colectomy.
RCTs,
observational
animal studies
Limited to English. Inclusion/exclusion of high
and mid rectal cancer is not clearly specified.
Chose not to pool data. Overlap with
Chapman 2001 [19].
Vardulaki/NICE
2000 [18], (UK)
2000 Colorectal cancer. Excluded: case series of < 10
patients.
RCTs,
observational
Extensive methodological description. Rigorous
assessment of heterogeneity. Pooling of RCTs
and observational data performed separately to
avoid bias (for some outcomes). Statistical
manipulations to overcome data limitations.
Chapman 2001
[19], (Australia)
July 1999 Colon cancer (right, left/sigmoid). Excluded:
transverse colectomy, APR, total colectomy.
RCTs,
observational
Limited to English. Inclusion/exclusion of high
and mid rectal cancer is not clearly specified.
Chose not to pool data. Overlap with
Chapman 2000 [17].
Yong 2001 [20],
(UK)
March
1997
Any colorectal pathology (all operation types) Observational;
no RCT found
Modification of inclusion/exclusion criteria from
protocol based on available studies. Only 13/42
studies had only malignant disease. Pooled
certain outcomes by calculating weighted
means.
Korolija 2003 [21],
(Croatia)
January
2000
’Colorectal procedures’, unclear RCTs,
observational
No inclusion/exclusion criteria provided. Not
mentioned whether RCTs included (two
identified in reference list). Chose to pool
outcomes from RCTs, observational studies,
case series together (no mention of
appropriateness).
Abraham 2004
[22], (Australia)
December
2002
Colorectal cancer (right hemicolectomy, left
hemicolectomy, rectosigmoid resection, APR,
others)
RCTs Limited to English. Study selection on basis of
reported outcomes.
Reza/UETS 2004
[23], (Spain)
September
2004
Colorectal cancer. Excluded: combination of
benign and malignant pathologies, immune
outcomes.
RCTs, systematic
reviews, meta-
analyses
In Spanish. Pre-2000 RCTs not included. No
pooling of outcomes except survival and
recurrence (reason unclear).
Poutignat/Haute
Autorité de Santé
2005 [24],
(France)
2003 Colorectal cancer. Excluded: metastatic disease,
combined benign and malignant pathologies,
non-intention-to-treat studies or those excluding
converted patients.
RCTs,
observational,
meta-analysis
In French, limited to English and French.
Unclear from text whether inclusion/exclusion
criteria chosen a priori or after literature search
by group of experts. Chose not to pool
outcomes, qualitative analysis.
Manterola 2005
[25], (Chile)
December
2002
Colon cancer (right, transverse, left, sigmoid).
Excluded: rectal cancer, perforated or
obstructing cancer, metastasis, recurrent cancer,
invasion into adjacent bowel/organs, polyps.
RCTs,
observational
In Spanish, limited to English, Spanish, French,
Italian. Methodology score created by review
authors. Controlled series and RCTs broken
down into individual case series yielding 6
laparoscopy and 11 open series in total.
Schwenk 2005
[26], (Germany)
January
2005
Colorectal pathologies (benign or malignant, for
curative or palliative resection)
RCTs Cochrane Review, protocol published in 2001.
Extensive methodological description. Results
for different pathologies pooled together.
Aziz 2006 [27],
(UK)
2004 Rectal cancer (described as anterior resection or
APR)
RCTs,
observational
Extensive quantitative assessment of
heterogeneity. Results for RCTs and
observational studies pooled (no sensitivity
analysis comparing RCT to observational data).
Tjandra 2006 [28],
(Australia)
September
2005
Colon and rectosigmoid cancer. Excluded: rectal
cancer, distant metastases.
RCTs Limited to English. Effect of heterogeneity on
results not clear/not documented.
Reza 2006 [29],
(Spain)
November
2005
Colorectal cancer. Excluded: papers with mixed
malignant/benign populations, immune function
as outcome.
RCTs, systematic
reviews
Pre-2000 RCTs not included. Limited
description of methodology. No pooling of
outcomes except survival and recurrence
(reason unclear).
Breukink 2006
[30], (The
Netherlands)
August
2006
Rectal cancer (undergoing total mesorectal
excision)
RCTs,
observational
Cochrane Review, protocol published in 2005.
Primary outcome: disease-free survival. Chose
not to pool survival data; qualitative analysis.
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published in 2005 or later. Three groups published
updates of their own reviews [10,17,19,23,29,39].
Because these were not labeled as updates in the titles
or abstracts, they were included as independent reviews.
A majority of reviews (n = 18, 67%) were published in
traditional print journals, while the remainder
comprised commissioned reports (n = 4, 15%)
[16,17,23,24], Cochrane Reviews (n = 3, 11%) [26,30,38],
and Health Technology Assessment (HTA) report (n =
2, 7.4%) [10,18]. The mean 5-year impact factor asso-
ciated with published reports was 4.02 (n = 20, 95% CI:
3.07 to 4.96). These originated in 12 countries, with
Europe (n = 14, 52%) and Australia (n = 5, 19%)
Table 2 Characteristics of included reviews (Continued)
Gao 2006 [31],
(China)
June 2005 Rectal cancer RCTs,
observational
Outcomes considered were selected post hoc
after reviewing selected literature. Meta-analysis
of RCT and observational data. Incomplete
assessment of heterogeneity.
Murray 2006 [10],
(UK)
May 2005 Colorectal cancer (including laparoscopic or
HALS, excluding palliative surgery)
RCTs, IPD meta-
analyses
HTA report (commissioned), protocol published
in 2005. Pre-2000 RCTs identified from existing
systematic reviews. Extensive description of
methodology, rigorous assessment of
heterogeneity. Academic-in-confidence data
obtained from other authors removed from
final report. Includes economic evaluation.
Kahnamoui 2007
[32], (Canada)
2004 Colorectal cancer (right, left, sigmoid, anterior
resection, APR)
RCTs Defined primary outcome: cancer-related
mortality. Extensive methodological description.
Quality appraisal list designed by authors.
Noel 2007 [33],
(USA)
January
2005
Colorectal cancer, IBD, diverticular disease RCTs,
observational
(controlled)
Limited to English. Excluded historical controls
with < 50% overlap in accrual periods.
Combination of RCT and non-RCT data. No
assessment of methodological quality.
Bonjer 2007 [34],
(The Netherlands)
2006 Colon cancer (rectal cancer included in at least
one of trials)
RCTs Minimum 150 patients with primary outcomes
of survival. Authors of review are primary
investigators in four included trials. Meta-
analysis of individual patient data with 3 years
of follow-up data.
Jackson 2007
[35], (USA)
February
2006
Colorectal cancer (colon and rectosigmoid as
per inclusion criteria, but selected RCTs include
rectal cancers). Excluded: benign pathologies.
RCTs Primary outcome: survival and recurrence.
Inclusion/exclusion of mid and low rectal
cancer is not clearly specified. Meta-analysis of
survival outcomes using time-to-event data.
Significant assessment of heterogeneity.
Abraham 2007
[36], (Australia)
December
2003
Colorectal cancer (non-metastatic, treated with
intention to cure). Excluded: uncontrolled series.
Observational Limited to English. Limited to end of 2003.
Quality assessment of papers performed but
not utilized in analysis (to be reported
separately). Limited assessment of
heterogeneity.
Kuhry 2007 [37],
(Norway)
April 2006 Colorectal cancer RCTs In Norwegian, limited to English. Very limited
methodological description.
Kuhry 2008 [38],
(Norway)
January
2008
Colorectal cancer (reporting long-term result,
non-metastasized carcinoma)
RCTs Cochrane review, protocol published 2002.
Meta-analysis of survival outcomes using time-
to-event data. Sensitivity analyses performed
separately for colon and rectum.
Lourenco 2008
[39], (UK)
May 2007 Colorectal cancer. Excluded: patients undergoing
palliative treatment.
RCTs, IPD meta-
analyses
Pre-2000 RCTs identified from existing
systematic reviews. Extensive description of
methodology. Overlap with Murray 2006 [10].
Anderson 2008
[40], (USA)
November
2007
Rectal cancer. Excluded: tumors invading
adjacent organs, previous pelvic surgery,
contraindications to pneumoperitoneum,
obstruction, perforation, studies which did not
report rectal cancer outcomes separately.
RCTs,
observational
Limited to English language. RCT and
observational studies pooled together.
Liang 2008 [41],
(China)
January
2007
Colorectal cancer. Excluded: emergency surgery
(obstruction, perforation), known prohibitive
adhesions, studies for which colorectal cancer
patients could not be analyzed separately from
patients with benign pathologies.
RCTs Limited to English. Extensive assessment of
heterogeneity.
aLaparoscopic versus open radical oncologic resection is the intervention under study unless stated otherwise.
APR = abdominoperineal resection; HALS = hand-assisted laparoscopic surgery; HTA = Health Technology Assessment; IBD = inflammatory bowel disease; IPD =
individual patient data; RCT = randomized controlled trials.
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presented in non-English languages, including French (n
= 2), Spanish (n = 2), and Norwegian (n = 1).
Among included reviews, four (15%) addressed exclu-
sively rectal cancer [27,30,31,41], one (3.7%) reviewed
only colon cancer [25], whereas the remainder were less
specific and identified ‘colorectal cancer’ as their popula-
tion of choice (Tables 2 and 3). This descriptor led to
contradictions in certain papers, as the authors some-
times specifically excluded rectal cancer, but then went
on to include papers with ‘rectosigmoid cancers’ or
‘anterior resections’ [17,19,34]. A total of four (15%)
reviews were wide in scope and addressed the laparo-
scopic treatment of all colorectal pathologies, of which
colorectal cancer was a subset of patients [16,20,21,33].
All reviews sought to find studies comparing laparo-
scopic and open radical resection for cancer. One early
paper found no controlled study, and was thus limited
to case series of laparoscopic surgery for colorectal can-
cer [16]. Right hemicolectomy, left hemicolectomy, and
sigmoid resection were the most commonly included
types of colonic resections. All publications not limited
exclusively to rectal cancer included those three proce-
dures. In contrast, studies including transverse colec-
tomies were frequently excluded by review authors
[17,19,22,32].
All reviews except one set out to include RCTs as part
o ft h e i ra n a l y s e s( T a b l e2 ) .O n eg r o u pc h o s et of o c u s
solely upon observational studies [36]. A total of 13
( 4 8 % )r e v i e w sa l l o w e do n l yR C T sa sp a r to ft h e i ri n c l u -
sion criteria. Of these, 77% were published in 2006 or
later. One such group selected only four larger RCTs,
and carried out a meta-analysis of individual patient
data [34]. Two reviews whose last literature searches
were in 1993 [16] and 1997 [20], respectively, were
unable to identify any published RCTs. As a result, both
groups presented only observational studies.
Table 3 provides an overview of the purposes, disease
processes, and outcomes addressed by each systematic
review. The self-described purposes were highly compar-
able, with most papers choosing to address issues of effi-
cacy or effectiveness in broad terms. Long-term
oncologic outcomes were sought by 19/27 reviewers
(70%), while oncologic surrogates were found in 22 (81%)
reviews. Similarly, operative and short-term postoperative
outcomes were analyzed in 74% (n = 20) and 78% (n =
21) of reviews, respectively. A total of 13 (48%) reviews
addressed all 4 outcomes types, while 18 (67%) included
at least 3 of the 4. Table 3 reveals significant overlap in
study purposes and outcomes. In contrast, long-term
operative outcomes (n = 4, 15%) and perioperative qual-
ity of life (n = 6, 22%) were much less frequently included
in the current group of systematic reviews.
Methodological quality
The included systematic reviews were generally of low
to moderate quality. The mean AMSTAR methodologi-
cal quality score was 5.8 (95% CI: 4.6 to 7.0). A total of
eight reviews (30%) achieved a score of 9 or greater, and
can be considered of high methodological quality. The
quality of reviews appears to have improved modestly in
time (Figure 2), with all but one high-quality review
having been published in 2005 or later. Among high-
quality reviews, three were published in traditional jour-
nals [32,35,39], three were Cochrane Reviews [26,30,38],
and two were HTA reports [10,18].
The composite of individual items within the
AMSTAR score is presented in Figure 3. Most review
groups defined their research question and inclusion
criteria ap r i o r i(20/27, 74%), and documented the eva-
luation of the scientific quality of included studies (20/
27, 74%). Similarly, 70% of systematic reviews used
appropriate methods to combine individual study
results (n = 19), and can be considered to have
reached appropriate conclusions that reflected the
methodological quality assessment of their selected
papers (n = 19). In contrast, few groups addressed the
possibility of publication bias (7/27, 26%), provided
evidence of a duplicate study selection and data extrac-
tion process (10/27, 37%), listed all included and
excluded studies (10/27, 37%), or avoided limiting their
search or inclusion of studies on the basis of publica-
tion status (9/27, 33%).
Synthesis of reviewed outcomes
The primary outcome of overall survival was pooled
quantitatively in ten reviews (Figure 4 and Additional
file 2). Most authors presented this data as a dichoto-
mous outcome (alive/dead) at maximum follow-up.
After meta-analysis, this data was presented as odds
ratios (OR), risk ratios (RR), and Stouffer’sc o m p o s i t eZ
(ZC). Two groups presented this outcome as time-to-
event data by pooling hazard ratios (HR), using methods
relying on the estimation of HR from Kaplan-Meier
curves. Finally, another group also presented a HR that
was derived from an individual patient data meta-analy-
sis. No significant difference in overall survival was
found between laparoscopic and open surgery for color-
ectal cancer across all meta-analytic comparisons. The
direction of effect for all analyses favored laparoscopy,
except for two which were conducted on observational
studies and using a subset of studies with independent
patient data [18,34].
All other pooled outcomes, except for the total num-
ber of harvested lymph nodes, yielded comparable non-
significant results. These findings are not presented in
the main text, but are available in Additional file 2.
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Disease process Outcomes reviewed
Review Purpose Colon
cancer
Rectal
cancer
Other Operative Short-term
postoperative
Oncologic
surrogate
Long-term
oncologic
Long-
term
other
QoL
Bernard
1994 [16]
Safety, efficacy Y Y Y Y Y Y Y
Chapman
2000 [17]
Safety, efficacy Y X Y Y Y Y
Vardulaki
2000 [18]
Effectiveness, cost
effectiveness
YY Y Y Y Y
Chapman
2001 [19]
Safety, efficacy Y X Y Y Y Y
Yong 2001
[20]
Effectiveness Y Y Y Y Y Y Y
Korolija 2003
[21]
Extent of oncologic
resection
YYY Y
Abraham
2004 [22]
Safety, efficacy (short
term)
YY Y Y Y
Reza 2004
[23]
Safety, efficacy Y Y Y Y Y Y Y
Poutignat
2005 [24]
Safety, efficacy Y Y Y Y Y Y Y
Manterola
2005 [25]
Identify best therapeutic
option
YY Y
Schwenk
2005 [26]
Short-term benefits Y Y Y Y Y
Aziz 2006
[27]
Short/long-term results
(rectal)
YY YY Y
Tjandra 2006
[28]
Update short-term results Y Y Y Y Y
Reza 2006
[29]
Safety, efficacy Y Y Y Y Y Y
Breukink
2006 [30]
Safety, efficacy (rectal) Y Y Y Y Y Y
Gao 2006
[31]
Safety, efficacy, benefits
(rectal)
YY YY
Murray 2006
[10]
Effectiveness, cost
effectiveness
YY Y Y Y Y Y Y
Kahnamoui
2007 [32]
Non-inferiority survival/
perioperative results
YY Y Y Y Y
Noel 2007
[33]
Safety, efficacy (short
term)
YYY Y Y
Bonjer 2007
[34]
Safety (oncologic) Y X Y Y
Jackson
2007 [35]
Compare oncologic
results
YY Y Y
Abraham
2007 [36]
Safety, efficacy (non-RCT,
short term)
YY Y Y Y
Kuhry 2007
[37]
Not stated Y Y Y Y Y Y
Kuhry 2008
[38]
Evaluate long-term
outcomes
YY Y Y
Lourenco
2008 [39]
Update, effectiveness Y Y Y Y Y Y Y Y
Anderson
2008 [40]
Compare oncologic
outcomes (rectal)
YY Y
Liang 2008
[41]
Evaluate recurrence
outcomes
YY Y
QoL = quality of life; × = Unclear from descriptions whether includes high rectal cancers.
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Page 8 of 17Bibliographic analysis
The pattern of citations of previously published systema-
tic reviews is presented in Figure 5. In total, nine (33%)
reviews did not cite any pre-existing work. The maxi-
mum number of cited existing systematic reviews was
five, which was found in two reviews [29,40]. All other
studies cited zero to four pre-existing systematic
reviews. The mean number of cited existing reviews was
1.6 (95% CI: 1.0 to 2.2). The mean ratio of cited to total
existing systematic reviews was 0.16 (95% CI: 0.093 to
0.22), ranging from 0 to 0.5. All three Cochrane Reviews
(0, 0.048 to 0.091) and the more recent HTA report
(0.18) had citation ratios that were less than 0.2. There
was no correlation between the citation ratio and the
AMSTAR score (r = 0.047) or the journal’s5 - y e a r
impact factor (r = -0.099) for individual reviews. In
total, 13/26 pre-existing reviews were cited at least once,
with 5 of these accounting for 71% of all citations (29/
41) [17-19,22,26]. Figure 5 shows that five reviews were
cited disproportionately more frequently, and that all
five reviews were published in the earlier portion of the
literature review.
The current overview protocol identified 38 publica-
tions pertaining to 23 individual RCTs comparing
laparoscopic and open surgery for colorectal cancer
[46-83]. The patterns of citations of these RCTs are pre-
sented in Figure 6. Two systematic reviews did not cite
any RCTs. In the case of Bernard et al. [16], there were
no RCTs yet published in the literature. In the case of
Yong et al. [20], a total of ten RCT publications could
have been cited. The mean ratio of cited to total pub-
lished RCT reports was 0.45 (95% CI: 0.35 to 0.54), ran-
ging from 0 to 1. Excluding Abraham et al.[ 3 6 ] ,w h i c h
sought to analyze only observational studies, yielded a
c o m p a r a b l em e a nr a t i oo f0 . 4 6( 9 5 %C I :0 . 3 6t o0 . 5 6 ) .
Given that certain RCTs were published over multiple
papers, the ratio of cited to total published RCT reports
was recalculated using each trial as the denominator
rather than individual papers. This analysis yielded a
mean ratio of 0.56 (95% CI: 0.46, 0.65). A total of only
Figure 2 Assessment of Multiple Systematic Reviews (AMSTAR) methodological quality scores against time.R e dc i r c l e sr e p r e s e n t
Cochrane reviews and Health Technology Assessment (HTA) reports.
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Page 9 of 17four reviews identified at least 75% of RCT publications,
of which two were Cochrane Reviews and one was an
HTA report [10,26,28,38]. Reviews that selected rectal
cancer as their sole patient population had generally low
citation ratios, ranging from 0.13 to 0.39 [27,30,31,40].
Among all RCT publications, two were cited dispropor-
tionately more frequently than others. Indeed, the Bar-
celona trial by Lacy et al. [57] and the Clinical
Outcomes of Surgical Therapy (COST) trial [63] were
both cited by 90% of systematic reviews. Finally, the cor-
relation between the citation ratios and the AMSTAR
scores (r = 0.43), and between the ratios and the jour-
nal’s 5-year impact factors were moderate at best (r =
0.46).
Discussion
In this work, we have presented an overview of pub-
lished systematic reviews and meta-analyses comparing
laparoscopic and open surgery for colorectal cancer. We
have conducted an extensive review of the literature
using a highly sensitive search algorithm, and utilized
the framework proposed by the Cochrane Collaboration
[9] to synthesize 27 systematic reviews and meta-ana-
lyses published between 1994 and 2008. We have sum-
marized the major oncologic outcome of overall
survival, and provided a methodological appraisal of the
reviews. Finally, we have analyzed the citation patterns
of all included reviews in an attempt to understand the
perceived redundancy of this body of work.
The first major finding of this overview pertains to the
startling number of systematic reviews and meta-ana-
lyses identified in the literature on laparoscopic colorec-
tal cancer surgery. There were more reviews than
clinical trials, and 19 reviews were published within the
span of 4 years (2005 to 2008). Given that systematic
reviews are typically meant to be comprehensive in nat-
ure, this result is particularly surprising. This finding
can be explained in part by the decision of certain
reviewers to address only a subset of outcomes. That
being said, the results shown in Table 3 would suggest
that there is significant overlap between papers in terms
of review purpose and outcomes. This argument is
further supported by the large number of pooled ana-
lyses identified for the primary survival outcome in Fig-
ure 4 and in Additional file 2 in addition to the
consistency and congruence of this result across reviews.
In addition to variation in outcomes, other authors
have limited their review protocols with respect to dis-
ease subsets such as rectal cancer. This distinction may
also account for a portion of the large volume of pub-
lished systematic reviews, although it is unlikely to be a
major factor as only four groups have focused solely on
this population. More importantly, we argue that the
limitation of review protocols to rectal cancer is
Figure 3 Methodological quality of included reviews on the basis of individual Assessment of Multiple Systematic Reviews (AMSTAR)
items.
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primary trials are highly variable. Indeed, high rectal
lesions have been inconsistently defined both as recto-
sigmoid and rectal cancers, and this variation in termi-
nology has been translated to different inclusion and
exclusion criteria in systematic reviews. Given that high
rectal cancers are typically treated in a manner that is
more similar to sigmoid colon cancers, we argue that
rectal cancer is best considered as part of broader
reviews addressing colorectal cancer as a whole. Sensi-
tivity analyses can then be carried out to identify out-
come differences between colon and rectal cancer
populations.
In addition to the above-mentioned patient population
and outcomes factors, it is possible that the large num-
ber of systematic reviews be a result of a duplication of
research efforts on the part of individual investigators.
The analysis of citation patterns of pre-existing systema-
tic reviews presented in Figure 5 supports this hypoth-
esis. Indeed, we have identified that, on average, only
1.6 pre-existing reviews were referenced by individual
systematic reviews. More strikingly, this corresponds to
a mean ratio of cited to existing reviews of 0.16, indicat-
ing that, on average, 84% of existing systematic reviews
in the literature were not found or ignored by individual
review authors. This finding would support the argu-
ment that review authors either carry out poor literature
evaluations or choose not to take into account pre-exist-
ing work in performing or analyzing their own reviews.
Individual explanations are likely to vary, but it remains
that our findings provide evidence of a duplication of
research efforts in the literature.
Other examples of overlapping systematic reviews and
meta-analyses can be found in the literature. In one
Figure 4 Synthesis of overall survival across systematic reviews.
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Page 11 of 17such case, ten reviews pertaining to the use of N-acetyl-
cysteine for the prevention of contrast-associated
nephropathy were published within a 3-year span [84].
In that particular case study, the authors documented
varying quality and inconsistent recommendations.
Another such analysis was published in the field of
orthopedic surgery, in which different methods of ante-
rior cruciate ligament repair were compared [85]. A
total of 11 overlapping systematic reviews were identi-
fied in this case, with varying conclusions. Interestingly,
Figure 5 Citation of previously published systematic reviews.
Figure 6 Citation of previously published randomized controlled trials.
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of pre-existing systematic reviews.
Several academics have recently called for the registra-
tion of systematic reviews and their protocols [3,4].
Although the Cochrane Library currently acts as a cen-
tral repository of high-quality systematic reviews and
meta-analyses, it is clear from our analysis that most
reviewers publish their work in traditional print journals.
This interpretation is supported by Moher and collea-
gues, who reported that approximately 2,500 new sys-
tematic reviews are published annually, of which over
90% are found in specialty journals [2]. As such, a freely
accessible registration system would have several advan-
tages, including the early identification of pre-existing,
ongoing, or unpublished reviews, the prioritization of
research funding, and the enhancement of collaboration
between review groups, while minimizing the possibility
of research duplication. This body of information would
be of particular use to practicing surgeons who would
now have access to systematic reviews and meta-ana-
lyses through a single portal. Duplication of systematic
reviews may be minimized with the existence of such an
open-access registry, and identification of pre-existing
work would likely be enhanced.
The continuous publication of new trials in time leads
to the production and dissemination of new systematic
reviews as a means to provide a synthesis of the litera-
ture that relies upon the latest data. For systematic
reviews to be considered useful for end users, they must
be up to date. In the current study, at least three groups
of reviewers have provided updates of their own work in
subsequent publications [10,17,19,23,29,39]. However,
these were not specifically labeled as such, a finding that
may lead to confusion on the part of the reader. In con-
trast, all three Cochrane Reviews documented having
undergone substantive amendments since their original
publication, as a result of new data pertinent data in the
literature [26,30,38]. This difference between Cochrane
and non-Cochrane reviews is not surprising. Indeed,
Jadad et al.h a v ep r e v i o u s l yd e m o n s t r a t e dt h a to n l y3 %
of systematic reviews published in traditional journals
underwent update within 2 years of publication, com-
pared with 38% of Cochrane Reviews [86]. Although the
timing at which systematic reviews should be updated
remains controversial, it seems intuitive that, in a
rapidly progressing field of healthcare such as laparo-
scopic surgery for colorectal cancer, existing systematic
reviews should be updated frequently [87,88]. The case
for updating systematic reviews becomes particularly
compelling when one considers the large number of
overlapping reviews identified in this study, and when
registration of systematic reviews is considered.
The methodological quality of systematic reviews
included in this study was low to moderate. As
indicated, the mean AMSTAR score was 5.6, although
8/27 reviews achieved a score of ≥9. It is noteworthy
that all Cochrane reviews and HTA reports in this study
were classified as high-quality reviews. This result is
supported by existing work in the literature, which
demonstrated that Cochrane reviews have greater meth-
odological rigor than traditional print reviews [86].
Although many systematic reviews in this work were
deemed to have a comprehensive literature search (n =
16, 59%) on AMSTAR methodology scoring, few incor-
porated the gray literature (n = 9, 33%). As a result,
many reports fell short in their identification of pub-
lished trials. Indeed, the mean ratio of cited to existing
RCT reports was only 0.46 across reviews. It was only
marginally better at 0.56 if one considered actual trials
rather individual reports of trials which were sometimes
multiple (38 reports on 23 RCTs). Only one HTA report
[10] managed to identify all reports of existing trials.
This finding is concerning in that well conducted sys-
tematic reviews are meant to be comprehensive and
commonly believed to provide the highest degree of
healthcare evidence [4].
Many factors may explain the finding of incomplete
citation, including the differing patient populations and
outcomes examined in each review. This is particularly
relevant given the recent report by the ORBIT group on
outcome reporting bias and its potential impact upon
results of systematic reviews [89]. As highlighted in the
ORBIT study, it is highly important that systematic
reviews avoid excluding trials on the basis of a lack of
relevant data, as authors may have elected not to report
a given outcome. In addition, it is also likely that the
time between systematic review search completion and
dissemination in electronic or print format may account
for a portion of the poor citation of trials. We have
attempted to avoid this form of time lag bias by allow-
ing for a reasonable 1-year gray zone between citation
of RCTs and publication (Figures 5 and 6). However,
several systematic reviews had time lags to publication
in excess of 2 years [19-21,25,32,36] (Table 2), which
may partially account for a failure to identify more
recent RCTs. In addition to the above factors, it is also
likely that individual search strategies were not as com-
prehensive as should be, in order to identify all available
trials. In the current study, we have modified the highly
sensitive search algorithm developed by Murray and col-
leagues [10] and have identified at least two recent trials
that have not been cited in of the existing reviews
[71,73]. Moreover, at least four other reports of RCTs
were cited much less frequently than other reports of
trials published around the same time period
[49,54,59,68,70]. In contrast, two well known RCTs were
cited by almost all reviews [57,63]. Putting together the
above patterns of trials citations, we argue that the
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retrieved systematic reviews, due at least in part to
inadequate search strategies.
Our overview of all systematic reviews presenting data
on oncologic outcomes reveals several important find-
ings. First, we found no evidence of a consistent or con-
gruent difference in overall survival between patients
with colon cancer treated by laparoscopy or open sur-
gery. Similar conclusions can be drawn from other
oncologic outcomes (data not shown; Additional file 2).
This result is likely to be extendable to patients with
high rectal cancer as many large trials included this
pathology [62,66,76]. However, our analysis cannot be
extrapolated to those with mid or low rectal cancer, as
too few trials have included these patients. Results from
the large multicenter and multinational COLOR II [90],
ACOSOG Z6051 [91] trials will shed light onto this area
of uncertainty. That being said, it is important to note
that the above conclusion is limited by the lack of
proper analysis of time-to-event data. Indeed, only three
meta-analyses addressing overall survival presented their
data in the form of HR [34,35,38]. Instead, many
authors simply used pooled OR, which incorporate the
proportion of patients alive or dead at a given point in
time in each study. While this approach provides some
information on survival, it is potentially biased by vari-
able lengths of follow-up, different trial maturity, and
the incomplete utilization of available data from patient
censoring [38]. Because many RCT authors do not
report HR, statistical methods exist to generate such
estimates from Kaplan-Meier curves [92-94]. We advo-
cate that review groups should attempt to gather this
type of data when addressing survival or other oncologic
outcomes.
Conclusions
A large number of overlapping systematic reviews and
meta-analyses comparing laparoscopic and open surgery
for colorectal cancer can be identified in the literature.
The methodological quality of systematic reviews is gen-
erally low to moderate, as evidenced by the incomplete
identification of published trials. On the whole,
Cochrane Reviews and Health Technology Assessment
reports demonstrate higher quality indices than most
traditional print reviews. Survival outcomes are inconsis-
tently reported and time-to-event data are infrequently
included in pooled estimates. That being said, all pooled
estimates of overall survival comparing laparoscopic and
open surgery for colorectal cancer are congruent and
demonstrate no significant difference. There appears to
be evidence of duplication of research efforts among
review groups, as evidenced by overlapping review pur-
poses, populations, and outcomes, as well as by the poor
citation of pre-existing systematic reviews. Further
systematic reviews or meta-analyses are unlikely to be
justified without specifying a significantly different
research objective. This works lends support to the
registration and updating of systematic reviews.
Additional material
Additional file 1: Ovid MEDLINE (1950 to July Week 4 2008).
Additional file 2: Summary of oncologic outcomes.
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